HomeNATCOPHARM • NSE
add
Natco Pharma Ltd.
Nakaraang pagsara
₹1,374.75
Sakop ng araw
₹1,353.05 - ₹1,386.40
Sakop ng taon
₹752.45 - ₹1,639.00
Market cap
242.96B INR
Average na Volume
534.22K
P/E ratio
12.49
Dividend yield
0.42%
Primary exchange
NSE
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.71B | 32.94% |
Gastos sa pagpapatakbo | 4.35B | 8.42% |
Net na kita | 6.77B | 83.55% |
Net profit margin | 49.40 | 38.07% |
Kita sa bawat share | 37.81 | 83.54% |
EBITDA | 8.03B | 75.44% |
Aktuwal na % ng binabayarang buwis | 17.32% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 24.63B | 102.65% |
Kabuuang asset | 82.45B | 31.83% |
Kabuuang sagutin | 10.88B | 13.26% |
Kabuuang equity | 71.57B | — |
Natitirang share | 179.13M | — |
Presyo para makapag-book | 3.44 | — |
Return on assets | — | — |
Return on capital | 27.91% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 6.77B | 83.55% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Itinatag
1981
Headquarters
Website
Mga Empleyado
4,016
